STEMSIGHT
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
STEMSIGHT
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2021-01-01
Address:
Tampere, Western Finland, Finland
Country:
Finland
Website Url:
http://www.stemsight.fi
Total Employee:
1+
Status:
Active
Contact:
+358-50-4212233
Total Funding:
500 K EUR
Technology used in webpage:
Google Google Cloud
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
GammaDelta Therapeutics
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells
Joint Academy
Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Aapo Kiviniemi Chief Legal Officer @ StemSight
Chief Legal Officer
Anni Mörö COO @ StemSight
COO
2021-04-01
Tanja Ilmarinen Chief Scientific Officer @ StemSight
Chief Scientific Officer
2021-04-01
Laura Koivusalo founder and CEO @ StemSight
founder and CEO
2020-01-01
Heli Skottman Co-Founder @ StemSight
Co-Founder
2021-05-01
Founder
Investors List
Voima Ventures
Voima Ventures investment in Seed Round - StemSight
Avohoidon Tutkimussäätiö
Avohoidon Tutkimussäätiö investment in Seed Round - StemSight
Official Site Inspections
http://www.stemsight.fi Semrush global rank: 16.09 M Semrush visits lastest month: 1
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "StemSight"
StemSight | Curing Blindness With Stem Cells | Finland
Apr 8, 2025 StemSight de velops off-the-shelf cell therapies to address unmet medical needs in corneal blin dness. We are the pioneers of combining iPS-derived cells with functional biomaterials. Our primary goal is to accelerate …See details»
About Us - StemSight
StemSight's journey began with a genuine clinical need identified by ophthalmic surgeons, supported by a visionary group of scientists. But let's rewind to the year 2005. Professor Outi Hovatta, the grand old lady and pioneer of stem cell …See details»
Meet the Team - StemSight
Get to know StemSight team and board of directors. We are a team of passionate professionals with a mission to bring sight-restoring cell therapies to patients.See details»
StemSight - Vision Unlimited - LinkedIn
StemSight - Vision Unlimited has entered an exciting new phase of growth and we marked the occasion with the official opening of our new office and laboratory. This space is designed to support ...See details»
StemSight - Crunchbase Company Profile & Funding
StemSight closed its last funding round on Feb 13, 2025 from a Seed round. Who are StemSight 's competitors? Alternatives and possible competitors to …See details»
The gift of sight - BioTech startup StemSight raises €2.3 million to ...
Feb 13, 2025 StemSight, a Tampere-based BioTech startup developing stem cell therapies for vision restoration, has raised €2.3 million in funding to advance StemSight toward clinical trials …See details»
StemSight - Platform 6
Contact: laura.koivusalo@stemsight.fi Founders Laura Koivusalo Anni Mörö Heli Skottman Tanja Ilmarinen Overview We are developing off-the-shelf cell therapies for corneal blindness using …See details»
StemSight cures blindness with stem cells - Voima …
Sep 14, 2021 www.stemsight.fi. Contact info. Laura Koivusalo CEO laura@stemsight.fi. Inka Mero Voima Ventures Managing Partner inka.mero@voimaventures.com. Share This Story, Choose Your Platform! …See details»
StemSight: replacing what’s lost - eif.org
StemSight’s final product resembles a contact lens, made from a functional biomaterial. The lens-like material contains millions of cells designed to replace those lost on the surface of the eye. …See details»
STEM CELL -BASED THERAPIES FOR BLINDNESS
2021 | StemSight 2016 Patent filed 2017 2-year Business Finland Tutli (R2B) funding 2019 SPARK Finland New patents filed 2021 StemSight Oy established Tech licensed from TAU ...See details»
Our technology - stemsight.fi
StemSight's off-the-shelf cell therapy product could provide these patients with a cure to regain their vision. In the future, we aim to use the same stem cells to make other types of corneal cells, …See details»
Finland’s StemSight, first human stem cell startup from Finland ...
All female founded StemSight is the first human stem cell startup from Finland to receive funding, announcing a €500000 seed round from Voima Ventures.. Stemsight aims to help over 12 …See details»
Platform6 alumnus StemSight raises €2.3M to develop vision …
Feb 13, 2025 StemSight, a Platform6 alumni startup, has raised €2.3 million to advance its stem cell therapies for vision restoration. The round was led by Voima Ventures, with participation …See details»
StemSight secures EUR 2.3 million in funding - NLS
Feb 14, 2025 The investment will be used to advance StemSight toward clinical trials for limbal stem cell deficiency (LSCD), a specific type of corneal blindness. ... Xbrane in agreement to …See details»
Meet the Finnish team using stem cells to cure blindness
Sep 13, 2021 StemSight has just secured €500k in funding from deep tech investors Voima Ventures and Avohoidon Tutkimussäätiö. Corneal blindness. The condition Koivusalo’s team …See details»
News - StemSight
Nov 21, 2023 As part of StemSight's pledge to help patients suffering from Limbal Stem Cell Deficiency, we hosted our first ever public symposium on rare corneal disorders in Tampere …See details»
Finnish biotech startup StemSight secures €2.3M to advance vision ...
Feb 14, 2025 Finnish biotech startup StemSight, specializing in stem cell therapies for vision restoration, has secured €2.3 million in funding from Voima Ventures. The investment will …See details»
Finnish startup secures €2.3M to advance stem cell therapy for …
Feb 14, 2025 Tampere-based biotech startup StemSight has raised €2.3 million in funding to advance its stem cell-based therapy for limbal stem cell deficiency (LSCD), a condition that …See details»
StemSight | EU-Startups
Building on this experience, StemSight is developing new cell therapy products for the treatment of blindness. StemSight's first target indication is limbal stem cell deficiency (LSCD), a severe …See details»
☑️Stemsight Oy — Consulting Organization from
Stemsight Oy — Consulting Organization from Finland with 2-10 employees, has experience with Horizon Europe (2021 - 2027), it`s involved in Health, Research sectorsSee details»